optimizing chemotherapy in aml
Published 2 years ago • 89 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
0:45
optimizing chemotherapy combinations for aml
-
3:16
the optimization of induction chemotherapy for patients with aml
-
4:31
optimizing conventional chemotherapy in all
-
2:07
the importance of induction chemotherapy in the aml treatment
-
1:10
novel methods to assess the effectiveness of chemotherapy in aml patients: mrd
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:36
intensive induction chemotherapy vs hma/ven in npm1-mutant aml: a retrospective study
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
22:35
haploid induction and breeding : by dr. william rooney
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:42
novel treatment combinations in aml: what’s to come?
-
3:17
how can we improve the cost-effectiveness of aml treatment?
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
4:20
developments in therapies for aml - chemotherapy, targeted therapy and immunotherapy
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
0:53
an overview of optimal sequencing therapy in aml
-
2:34
the evolution of the aml treatment paradigm
-
7:27
menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches